Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

Magen, Ori, Waxman, Jacob G., Makov-Assif, Maya, Vered, Roni, Dicker, Dror, Hernán, Miguel A., Lipsitch, Marc, Reis, Ben Y., Balicer, Ran D., Dagan, Noa·2022·New England Journal of Medicine

DOI 10.1056/nejmoa2201688

Cited by (269)

Items 101–200 of 269

Recapping the Features of SARS-CoV-2 and Its Main Variants: Status and Future Paths
Miguel Angel Ortega, Cielo García Montero, Oscar Fraile‐Μartinez, Paolo C. Colet, Ardak Baizhaxynova, Kymbat Mukhtarova, Melchor Álvarez‐Mon, Kaznagul Kanatova, Ángel Asúnsolo, Antonio Sarría‐Santamera · 2022 · Journal of Personalized Medicine
Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study
Massimo Fabiani, Alberto Mateo‐Urdiales, Chiara Sacco, Maria Cristina Rota, Daniele Petrone, Marco Bressi, Martina Del Manso, Andrea Siddu, Valeria Proietti, Serena Battilomo et al. · 2022 · Vaccine
Fourth Dose of mRNA COVID-19 Vaccine Transiently Reactivates Spike-Specific Immunological Memory in People Living with HIV (PLWH)
Giulia Lamacchia, Lorenzo Salvati, Seble Tekle Kiros, Alessio Mazzoni, Anna Vanni, Manuela Capone, Alberto Carnasciali, Parham Farahvachi, Filippo Lagi, Nicoletta Di Lauria et al. · 2022 · Biomedicines
Effectiveness of mRNA vaccine against Omicron-related infections in the real world: A systematic review and meta-analysis
Guo, Kaixin, Ni, Peng, Chang, Shuailei, Jin, Yuefei, Duan, Guangcai, Zhang, Rongguang · 2023 · American Journal of Infection Control
Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
Grewal, Ramandip, Nguyen, Lena, Buchan, Sarah A, Wilson, Sarah E, Nasreen, Sharifa, Austin, Peter C., Brown, Kevin A., Fell, Deshayne B., Gubbay, Jonathan, Schwartz, Kevin L. et al. · 2022
Risk Factors Related to COVID-19 Reinfection and Fatality During the Omicron (BA.1/BA.2) Period in Korea
Ju Hee Lee, Ji Hae Hwang, Eun Jung Jang, Ryu Kyung Kim, Kil Hun Lee, Seon Kyeong Park, Jin Gwack, Young-Joon Park · 2023 · Journal of Korean Medical Science
Challenges to the Effectiveness and Immunogenicity of COVID-19 Vaccines: A Narrative Review with a Systematic Approach
Alexander A. Soldatov, Nickolay A. Kryuchkov, Горенков Дмитрий Витальевич, Ж. И. Авдеева, О. А. Свитич, Sergey S Soshnikov · 2025 · Vaccines
The Humoral Response of Patients With Cancer to Breakthrough COVID-19 Infection or the Fourth BNT162b2 Vaccine Dose
Idan Cohen, Salvatore Campisi‐Pinto, Orit Rozenberg, Colodner Raul, Gil Bar-Sela · 2023 · The Oncologist
The causal association between COVID-19 and herpes simplex virus: a Mendelian randomization study
Ming Yan, Li-yuan Xiao, Martin Gosau, Reinhard Edgar Friedrich, Ralf Smeets, Ling-ling Fu, Hong-chao Feng, Simon Burg · 2023 · Frontiers in Immunology
Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study
Jennifer H Ku, Lina S. Sy, Lei Qian, Bradley K. Ackerson, Yi Luo, Julia E. Tubert, Gina S. Lee, Ana Florea, Katia J. Bruxvoort, Fagen Xie et al. · 2023 · Vaccine
SARS-CoV-2 vaccine and increased myocarditis mortality risk: A population based comparative study in Japan
Sintaroo Watanabe, Rokuro Hama · 2022 · medRxiv
Effectiveness of a Messenger RNA Vaccine Booster Dose Against Coronavirus Disease 2019 Among US Healthcare Personnel, October 2021–July 2022
Ian D. Plumb, Nicholas M. Mohr, Melissa Hagen, Ryan E. Wiegand, Ghinwa K. Dumyati, Karisa K. Harland, Anusha Krishnadasan, Jade James-Gist, Glen R. Abedi, Katherine E. Fleming-Dutra et al. · 2023 · Open Forum Infectious Diseases
The second dose of COVID-19 vaccine booster hesitancy among health care workers in China: A multicenter cross-sectional study
Ling Zhang, Yijin Wu, Shu Jing, Xiaoyang Liu, T Ren, Xiaoyang Liu, Zhenwei Dai, Xiaofen Gu, Xu Chen, Weijun Xiao et al. · 2023 · American Journal of Infection Control
Impact of CoronaVac on Covid-19 outcomes of elderly adults in a large and socially unequal Brazilian city: A target trial emulation study
Higor S. Monteiro, Antonio S. Lima Neto, Rebecca J. Kahn, Geziel dos Santos de Sousa, Humberto A. Carmona, José S. Andrade, Márcia C. Castro · 2023 · Vaccine
Covid- 19 Vaccine-induced Myocarditis
Jaskaran Munjal, Sergio Mellado Flores, Muhammad Hamza Yousuf, Vasu Gupta, Ripudaman Singh Munjal, FNU Anamika, Vaidehi Alkeshbhai Mendpara, Priyanshi Shah, Rohit Jain · 2023 · Journal of Community Hospital Internal Medicine Perspectives
Vaccinating against a Novel Pathogen: A Critical Review of COVID-19 Vaccine Effectiveness Evidence
Bernard S. Black, David B. Thaw · 2023 · Microorganisms
Effectiveness of the fourth dose of COVID-19 vaccines against severe COVID-19 among adults 40 years or older in Brazil: a population-based cohort study
Felippe Lazar Neto, Matt D. T. Hitchings, Avnika B. Amin, Giovanny Vinícius Araújo de França, Margaret L. Lind, Mario Sergio Scaramuzzini Torres, Daniel Henrique Tsuha, Roberto Dias de Oliveira, Derek A. T. Cummings, Natalie E. Dean et al. · 2024 · The Lancet Regional Health - Americas
Cellular and humoral immune response to the fourth Pfizer-BioNTech COVID-19 vaccine dose in individuals aged 60 years and older
Esther Saiag, Yifat Alcalay, Or Marudi, Avi Orr‐Urtreger, David Hagin · 2022 · Vaccine
Effectiveness of A Fourth Dose of COVID-19 mRNA Vaccine in the Elderly Population During the Omicron BA.2 and BA.5 Circulation: A Nationwide Cohort Study in Korea (K-COVE)
Seon Kyeong Park, Young June Choe, Eun Jung Jang, Ryu Kyung Kim, Dosang Lim, Seonju Yi, Sangwon Lee, Geun‐Yong Kwon, Jee Yeon Shin, Sang‐Yoon Choi et al. · 2023 · Open Forum Infectious Diseases
Feasibility and Effectiveness of a Novel Intervention Integrating Physical Therapy Exercise and Dance Movement Therapy on Fall Risk in Community-Dwelling Older Women: A Randomized Pilot Study
Michal Pitluk, Einat Shuper Engelhard, Michal Elboim Gabyzon · 2023 · Healthcare
Three-year COVID-19 and flu vaccinations among medical residents in a tertiary hospital in Italy: The threat of acceptance decline in seasonal campaigns
Flavia Beccia, Alberto Lontano, Maria Francesca Rossi, Eleonora Marziali, Domenico Pascucci, Matteo Raponi, Paolo Emilio Santoro, Umberto Moscato, Patrizia Laurenti · 2023 · Human Vaccines & Immunotherapeutics
COVID-19 Vaccination Strategies and Their Adaptation to the Emergence of SARS-CoV-2 Variants
Paola Stefanelli, Giovanni Rezza · 2022 · Vaccines
SARS-CoV-2 infection among patients with autoimmune rheumatic diseases; comparison between the Delta and Omicron waves in Israel
Amir Bieber, Shay Brikman, Lena Novack, Snait Ayalon, Mahmoud Abu‐Shakra, Lior Zeller, Reuven Mader, Iftach Sagy · 2022 · Seminars in Arthritis and Rheumatism
A Review on the Impact of the SARS-CoV-2 Omicron Subvariant on Elderly Patients with Diverse Co-Morbidities
Avinash D. Khadela, Shruti Soni, Kaivalya Megha, Shivam U. Bhagat, Vivek P. Chavda · 2023 · Biologics
Effectiveness of XBB.1.5 Vaccines Against Omicron Subvariants
Dan-Yu Lin, Yi Du, Yangjianchen Xu, Sai Paritala, Matthew A. Donahue, Patrick Maloney · 2024 · Medical Research Archives
The Fourth Dose of mRNA COVID-19 Vaccine Following 12 Different Three-Dose Regimens: Safety and Immunogenicity to Omicron BA.4/BA.5
Sitthichai Kanokudom, Jira Chansaenroj, Nungruthai Suntronwong, Suvichada Assawakosri, Ritthideach Yorsaeng, Pornjarim Nilyanimit, Ratchadawan Aeemjinda, Nongkanok Khanarat, Preeyaporn Vichaiwattana, Sirapa Klinfueng et al. · 2023 · Vaccines
Blunted humoral immune response to the fourth dose of BNT162b2 COVID-19 vaccine in patients undergoing hemodialysis
Daisuke Kanai, Hiromichi Wakui, Masaaki Hanaoka, Tatsuya Haze, Kengo Azushima, Satoru Shinoda, Shunichiro Tsukamoto, Shinya Taguchi, Sho Kinguchi, Tomohiko Kanaoka et al. · 2023 · Clinical and Experimental Nephrology
Changes within the P681 residue of spike dictate cell fusion and syncytia formation of Delta and Omicron variants of SARS-CoV-2 with no effects on neutralization or infectivity
Alona Kuzmina, Dina Korovin, Ido Cohen-Lass, Nofar Atari, Aner Ottolenghi, Pan Hu, Michal Mandelboim, Benyamin Rosental, Elli Rosenberg, Felipe Diaz‐Griffero et al. · 2023 · Heliyon
Robust neutralizing antibody responses after single-dose BNT162b2 vaccination at long intervals from prior SARS-CoV-2 infection and ceiling effect with repeated vaccination
Ji Yun Noh, Hee Jin Cheong, Woo Joo Kim, Ju‐Yeon Choi, Hye Won Lee, Sung Soon Kim, Byoungguk Kim, Joon Young Song · 2022 · Journal of Infection
The fourth COVID-19 vaccine dose increased the neutralizing antibody response against the SARS-CoV-2 Omicron (B.1.1.529) variant in a diverse Brazilian population
Jéssica Pires Farias, Robert Andreata‐Santos, Ruth Dálety da Silva Brito, Milena Silva Souza, Mayanna Moreira Costa Fogaça, Josilene Ramos Pinheiro, Edgar Ferreira da Cruz, Willian Liang, Rafael da Conceição Simões, Wilson Barros Luiz et al. · 2023 · Microbiology Spectrum
Long-term levels of protection of different types of immunity against the Omicron variant: a rapid literature review
Sabina Rodriguez Velásquez, Loza Biru, Sandrine Hakiza, Muaamar Al‐Gobari, Isotta Triulzi, Jyoti Dalal, Camille B. Valera, Sara Botero Mesa, Olivia Keiser · 2024 · Swiss Medical Weekly
Boosting capacity of a fourth dose BNT162b2 in cancer patients
Yana Debie, Peter A. van Dam, Maria E. Goossens, Marc Peeters, Timon Vandamme · 2022 · European Journal of Cancer
An update on studies characterizing adaptive immune responses in SARS-CoV-2 infection and COVID-19 vaccination
Ricardo da Silva Antunes, Alba Grifoni, April Frazier, Daniela Weiskopf, Alessandro Sette · 2023 · International Immunology
SARS-CoV-2 vaccine breakthrough infection in the older adults: a meta-analysis and systematic review
Xiaohui Jing, Menglin Han, Xiaoxuan Wang, Li Zhou · 2023 · BMC Infectious Diseases
Short-Lived Antibody-Mediated Saliva Immunity against SARS-CoV-2 after Vaccination
Johannes Roth Madsen, Bettina Eide Holm, Laura Pérez‐Alós, Rafael Bayarri‐Olmos, Anne Rosbjerg, Kamille Fogh, Mia Marie Pries‐Heje, Dina Leth Møller, Cecilie Bo Hansen, Line Dam Heftdal et al. · 2023 · Microbiology Spectrum
Kinetics of neutralising antibodies against Omicron variant in Vietnamese healthcare workers after primary immunisation with ChAdOx1-S and booster with BNT162b2
Nguyen Van Vinh Chau, Lam Anh Nguyet, Nguyen Thanh Dung, Vo Minh Quang, Nguyen Thanh Truong, Le Mau Toan, Le Manh Hung, Dinh Nguyen Huy Man, Dao Bach Khoa, Nguyen Thanh Phong et al. · 2022 · medRxiv
Antibody Response After a Fifth Dose (Third Booster) of BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers
Esther Saiag, Ronni Gamzu, Hagit Padova, Yael Paran, Ilana Goldiner, Neta Cohen, David Bomze · 2024 · Journal of Clinical Medicine
Use of immunology in news and YouTube videos in the context of COVID-19: politicisation and information bubbles
Rachel Surrage George, Hannah Goodey, Maria Antonietta Russo, Rovena Tula, Pietro Ghezzi · 2024 · Frontiers in Public Health
Dynamic clade transitions and the influence of vaccination on the spatiotemporal circulation of SARS-CoV-2 variants
Cecília Ártico Banho, Beatriz de Carvalho Marques, Lívia Sacchetto, Ana Karoline Sepedro Lima, Maisa Carla Pereira Parra, Alex Ranieri Jerônimo Lima, Gabriela Ribeiro, Antonio Jorge Martins, Cláudia Renata dos Santos Barros, Maria Carolina Elias et al. · 2024 · npj Vaccines
Humoral response after SARS-CoV-2 booster vaccination in haemodialysis patients with and without prior infection
Louise Füeßl, Tobias Lau, Simon Rau, Ron Regenauer, Michael Paal, Sandra E. Hasmann, Florian M. Arend, Mathias Bruegel, Daniel Teupser, Michael Fischereder et al. · 2022 · Clinical Kidney Journal
Assessment of Postvaccination Neutralizing Antibodies Response against SARS-CoV-2 in Cancer Patients under Treatment with Targeted Agents
Flora Zagouri, Alkistis Maria Papatheodoridi, Michalis Liontos, Αlexandros Briasoulis, Aimilia D. Sklirou, Efthymia Skafida, Oraianthi Fiste, Christos Markellos, Αngeliki Andrikopoulou, Konstantinos Koutsoukos et al. · 2022 · Vaccines
The role of Israeli researchers in the scientific literature regarding COVID-19 vaccines
Bruce Rosen, Nadav Davidovitch, Gabriel Chodick, Avi Israeli · 2022 · Israel Journal of Health Policy Research
Immunogenicity and SARS-CoV-2 Infection following the Fourth BNT162b2 Booster Dose among Health Care Workers
Yael Shachor‐Meyouhas, Halima Dabaja‐Younis, Avi Magid, Ronit Leiba, Moran Szwarcwort‐Cohen, Ronit Almog, Michal Mekel, Avi Weissman, Gila Hyams, Vardit Gepstein et al. · 2023 · Vaccines
Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SYS6006, as a fourth-dose booster following three doses of inactivated vaccines in healthy adults: an open-labeled Phase 1 trial
Yuzhou Gui, Ye Cao, Jiajin He, Chunyang Zhao, Wei Zheng, Ling Qian, Jie Cheng, Chengyin Yu, Yu Chen, Kun Lou et al. · 2023 · Life Metabolism
Outcomes and characteristics of patients hospitalized for COVID-19 in British Columbia, Ontario and Quebec during the Omicron wave
Terry Lee, Matthew Pellan Cheng, Donald Cuong Vinh, Todd Campbell Lee, Karen C. Tran, Brent W. Winston, David D. Sweet, John H. Boyd, Keith R. Walley, Greg Haljan et al. · 2023 · CMAJ Open
Risk factors for death and illness severity in vaccinated versus unvaccinated COVID-2019 inpatients: a retrospective cohort study
Guilherme Jorge Costa, José Roberto da Silva, Caio Cesar Arruda da Silva, Tiago Pessoa Lima, Mariana Menezes Costa, Marcos Henrique Oliveira Sousa, Gabriela Carla dos Santos Costa, José Iran Costa Júnior, Mozart Júlio Tabosa Sales · 2023 · Jornal Brasileiro de Pneumologia
A translational framework of genoproteomic studies for cardiovascular drug discovery
Zhao Yang, Jie V. Zhao, Yue Qi, Xuan Deng, Zhili Ji, Jing Liu · 2024 · npj Cardiovascular Health
COVID-19 Vaccine Booster Dose Willingness among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional Study
Mohammad Shehab, Fatema Alrashed, Ahmad Alfadhli · 2022 · Vaccines
Vaccine-induced and hybrid immunity to SARS-CoV-2 after three or four doses of BNT162b2 - results from 22 months follow-up of a healthcare workers cohort, Israel, 2020-2022
Michael L. Edelstein, Karine Beiruti Wiegler, Hila Ben-Amram, Netta Beer, Christian Sussan, Perachel Batya, Salman Zarka, Kamal Abu Jabal · 2023 · International Journal of Infectious Diseases
Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine
Jacob G. Waxman, Ori Magen, Miguel Ángel Hernán · 2022 · New England Journal of Medicine
Evolution of SARS-CoV-2 Spikes shapes their binding affinities to animal ACE2 orthologs
Weitong Yao, Yujun Li, Danting Ma, Xu-Dong Hou, Haimin Wang, Xiaojuan Tang, Dechun Cheng, He Zhang, Chengzhi Du, Hong Pan et al. · 2023 · Microbiology Spectrum
Impact of the COVID-19 vaccine booster strategy on vaccine protection: a pilot study of a military hospital in Taiwan
Yuli Wang, Shu-Tsai Cheng, Ching‐Fen Shen, Shu-Wei Huang, Chao‐Min Cheng · 2023 · Clinical and Experimental Vaccine Research
Long Covid Symptom Clusters, Correlates and Predictors in a Highly Vaccinated Australian Population in 2023
Essa Tawfiq, Rosalie Chen, Damian Alexander Honeyman, Rebecca Smullin Dawson, Mohana Priya Kunasekaran, Adriana Notaras, Deepti Gurdasani, Helen Skouteris, Darshini Ayton, Chandini Raina MacIntyre · 2025 · Health Expectations
Future COVID-19 Booster Vaccine Refusal in Healthcare Workers after a Massive Breakthrough Infection Wave, a Nationwide Survey-Based Study
Fuying Gu, Huiying Lin, Zhenqiang Chen, Gareth Ambler, Xinyan Chen, Xiaoling Chen, Pincang Xia, Nan Liu, Houwei Du · 2023 · Vaccines
Survival benefit of a third dose of the COVID-19 vaccine among hemodialysis patients: A prospective cohort study
Tz‐Heng Chen, Yang Ho, Hsin-Ling Tai, Yuan-Chia Chu, Yao‐Ping Lin, Chih‐Yu Yang, Wei‐Cheng Tseng, Shuo‐Ming Ou, Ming‐Tsun Tsai, Jinn-Yang Chen et al. · 2023 · Journal of Microbiology Immunology and Infection
Are people living with HIV have a low vulnerability to omicron variant infection: results from a cross-sectional study in China
Yuting Tan, Songjie Wu, Wei Guo, Jie Liu, Fangzhao Ming, Shi Zou, Weiming Tang, Ke Liang, Junjun Yang · 2023 · BMC Infectious Diseases
Design and analysis heterogeneity in observational studies of COVID-19 booster effectiveness: A review and case study
Sabir Meah, Xu Shi, Lars G. Fritsche, Maxwell Salvatore, Abram Luther Wagner, Emily Toth Martin, Bhramar Mukherjee · 2023 · Science Advances
Dynamics of Anti-SARS-CoV-2 IgA and IgG Responses and Their Protective Effect against Fatal Disease after Booster COVID-19 Vaccination
Matthaios G. Speletas, Ioanna Voulgaridi, Zacharoula Bogogiannidou, Styliani Sarrou, Maria A. Kyritsi, Aikaterini Theodoridou, Katerina Dadouli, Alexia Matziri, Alexandros Vontas, Dimitra A. Pappa et al. · 2023 · Vaccines
In silico clinical studies for optimal COVID-19 vaccination schedules in patients with cancer
Chrysovalantis Voutouri, Corey Hardin, Vivek Naranbhai, Mohammad R. Nikmaneshi, Melin Janardan Khandekar, Justin F. Gainor, Triantafyllos Stylianopoulos, Lance L. Munn, Rakesh K. Jain · 2024 · Cell Reports Medicine
Protectivity of COVID-19 Vaccines and Its Relationship with Humoral Immune Response and Vaccination Strategy: A One-Year Cohort Study
Ferdi Tanır, Burak Mete, Hakan Demırhındı, Ertan Kara, Ersin Nazlıcan, Gülçin Dağlıoğlu, Filiz Kibar, Salih Çetiner, Ceren Kanat · 2022 · Vaccines
SARS-CoV-2 Antibody Effectiveness Is Influenced by Non-Epitope Mutation/Binding-Induced Denaturation of the Epitope 3D Architecture
Moffat M. Malisheni, Matthew Bates, Albert Anatolyevich Rizvanov, Paul A. MacAry · 2022 · Pathogens
Homologous booster immunization with an inactivated vaccine induced robust antibody response in healthcare workers: A retrospective study
Guiping Wen, Min Zhu, Lirong Li, Xiujuan Li, Huiming Ye, Yulin Zhou · 2023 · Frontiers in Immunology
Severity of Omicron Subvariants and Vaccine Impact in Catalonia, Spain
Víctor López de Rioja, Luca Basile, Aida Perramon‐Malavez, Érica Martínez-Solanas, Daniel López, Sergio Medina Maestro, Ermengol Coma, Francesc Fina Avilés, Clara Prats, Jacobo Mendioroz et al. · 2024 · Vaccines
Anti-SARS-CoV-2 Antibodies Level and COVID-19 Vaccine Boosters among Healthcare Workers with the Highest SARS-CoV-2 Infection Risk—Follow Up Study
Dagny Lorent, Rafał Nowak, Magdalena Figlerowicz, Luiza Handschuh, Paweł Zmora · 2024 · Vaccines
P681 mutations within the polybasic motif of spike dictate fusogenicity and syncytia formation of SARS CoV-2 variants
Alona Kuzmina, Nofar Atari, Aner Ottolenghi, Dina Korovin, Ido Cohen-Lass, Benyamin Rosental, Elli Rosenberg, Michal Mandelboim, Ran Taube · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Age-specific patterns of all-cause mortality across COVID-19 booster dose groups in two Japanese municipalities: an exploratory analysis
Y IWAMOTO, Hiroshi Kusunoki, Yukari Kamijima, Ryota Sakai, Yumi Watanabe, Hideki Kakeya · 2026 · Frontiers in Public Health
Immunological responses and adverse reactions of the heterologous second booster dose of BNT162b2 after two-dose CoronaVac for COVID-19 vaccination in healthcare workers of Faculty of Medicine, Naresuan University
Supawadee Makanut, Apirath Wangteeraprasert, Wittawat Jitpewngam, Jatuporn Ngoenkam, Sutatip Pongcharoen · 2023 · Vaccine
COVID-19 Infection and Response to Vaccination in Chronic Kidney Disease and Renal Transplantation: A Brief Presentation
Stamatia Stai, Γεώργιος Λιούλιος, Michalis Christodoulou, Efstratios Kasimatis, Asimina Fylaktou, Maria J. Stangou · 2022 · Life
Fourth mRNA vaccination increases cross-neutralizing antibody titers against SARS-CoV-2 variants, including BQ.1.1 and XBB, in a very elderly population
Silvia Sutandhio, Koichi Furukawa, Yukiya Kurahashi, Maria Istiqomah Marini, Gema Barlian Effendi, Natsumi Hasegawa, Hanako Ishimaru, Mitsuhiro Nishimura, Jun Arii, Yasuko Mori · 2023 · Journal of Infection and Public Health
Humoral response against spike protein enhanced by fifth and sixth COVID-19 mRNA vaccine in the uninfected and infected subjects
Hideaki Kato, Takayuki Kurosawa, Kazuo Horikawa, Yayoi Kimura, Kei Miyakawa, Akihide Ryo, Atsushi Goto · 2023 · Human Vaccines & Immunotherapeutics
What a second booster dose of mRNA COVID-19 vaccines tells us
Paul Loubet, Odile Launay · 2022 · The Lancet Infectious Diseases
COVID-19 in Older Adults at the Time of the Omicron Variant
Maurizio Gabrielli · 2022 · Journal of Clinical Medicine
Expected cost effectiveness of the fourth dose of COVID-19 vaccine against the omicron variant of COVID-19: a preliminary report.
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit · 2022 · PubMed Central
Optimizing the nucleic acid screening strategy to mitigate regional outbreaks of SARS-CoV-2 Omicron variant in China: a modeling study
Yun Yin, Yuanhua Liu, Mengwei Duan, Xiyang Xie, Jie Hong, Jiaqi Huang, Ke Li, Jin Shi, Xi Chen, Hongyan Guo et al. · 2023 · Infectious Diseases of Poverty
COVID-19 vaccination benefits in preventing severe disease in mild-to-moderate cases: An analysis in the first specialized hospital for COVID-19 in Japan
Masanori Kobayashi, Atsushi Miyamoto, Tetsuya Watanabe, Kenji Sawa, Kanako Sato, Kazuhiro Yamada, Naoko Yoshii, Koichi Yamada, Kengo Kawamoto, Masato Uji et al. · 2023 · Respiratory Investigation
Fourth dose of BNT162b2 vaccine for patients with autoimmune rheumatic diseases in a nationwide setting
Amir Bieber, Shay Brikman, Lena Novack, Ran Abuhasira, Abdallah Fawaz, Mahmoud Abu‐Shakra, Lior Zeller, Eduard Ling, Reuven Mader, Iftach Sagy · 2023 · Rheumatology
Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters
Catherine Berry, Vincent Pavot, Natalie G. Anosova, Michael Kishko, Lu Li, Tim Tibbitts, Alice Raillard, Sylviane Gautheron, Sheila Cummings, Dinesh S. Bangari et al. · 2023 · Communications Medicine
Post-Pandemic Perspectives: Willingness, Risk Perception and Factors Influencing COVID-19 Booster Vaccine Uptake Among Thai Healthcare Workers and Vulnerable Populations
Amornphat Kitro, Wachiranun Sirikul, Chanachai Polpitakchai, Jinjuta Panumasvivat, Ranchana Yamsiri, Pacharee Tasena, Chutima Punyaphab, Chaiy Rungsiyakull, Ratana Sapbamrer, Penprapa Siviroj et al. · 2024 · Vaccines
Relative effectiveness and durability of booster doses of SARS-CoV-2 vaccines: A systematic review and meta-analysis
Di Liu, Yiwen Jiang, Shiyu Wang, Fu-Xiao Li, Teng-Fei Lin, Bingli Li, Zi-Yi Zhao, Qingping Yun, Nana Peng, Jiaxin Cai et al. · 2024 · The Innovation Medicine
Effectiveness of COVID-19 vaccines against severe COVID-19 among patients with cancer in Catalonia, Spain
Felippe Lazar Neto, Núria Mercadé‐Besora, Berta Raventós, Laura Pérez‐Crespo, Gilberto de Castro, Otavio Ranzani, Talita Duarte‐Salles · 2024 · Nature Communications
Single-cell transcriptome atlas of peripheral immune features to Omicron breakthrough infection under booster vaccination strategies
Yu-Wei Zhang, Shanshan Han, Qingshuai Sun, Tao Liu, Zixuan Wen, Mingxiao Yao, Shu Zhang, Qing Duan, Xiaomei Zhang, Bo Pang et al. · 2025 · Frontiers in Immunology
Impact of chemotherapy on humoral and cellular immune responses to COVID-19 vaccination in patients with solid tumors
Andrea Favalli, Giorgio Patelli, Paola Gruarin, Andrea Gobbini, Elisa Pesce, Sara Mariano, Mauro Bombaci, Francesca Vincenti, Lorena Donnici, Silvia Marchese et al. · 2025 · Frontiers in Immunology
Long-term observation of antibody titers against SARS-CoV-2 following vaccination
Kazuo Sugiyama, Chouji Suzuki, Masanori Aoyama, Nobuhiko TOYOTA, Nozomi Nakagawa, Makio Shozu, Kanji Nakai, Keiji Iwano · 2022 · Public Health in Practice
Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses
Saverio Giuseppe Parisi, Carlo Mengoli, Monica Basso, Ilaria Vicenti, Francesca Gatti, Renzo Scaggiante, Lia Fiaschi, Federica Giammarino, Marco Iannetta, Vincenzo Malagnino et al. · 2022 · Vaccines
Divergent SARS-CoV-2-specific T cell responses in intensive care unit workers following mRNA COVID-19 vaccination
Estefanía Salgado del Riego, María Laura Sáiz, Viviana Corte-Iglesias, B. Leoz Gordillo, Cristina Martín-Martín, Mercedes Rodríguez-Pérez, Dolores Escudero, Carlos López‐Larrea, Beatriz Suárez-Álvarez · 2022 · Frontiers in Immunology
Comparable humoral and cellular immunity against Omicron variant BA.4/5 of once‐boosted BA.1/2 convalescents and twice‐boosted COVID‐19‐naïve individuals
Chang Kyung Kang, Min‐Gang Kim, Seong‐wook Park, Yong‐Woo Kim, Chan Mi Lee, Pyoeng Gyun Choe, Wan Beom Park, Nam Joong Kim, Minji Kim, Soojin Lee et al. · 2023 · Journal of Medical Virology
Hope, health and cure: the meanings of the vaccine against COVID-19
Cynthia de Freitas Melo, Marina Pinheiro Accyoly Ferreira, Ícaro Moreira Costa, Samuel Lins, Ana Cristina Eberhardt · 2023 · Psico-USF
An Update on Complications Associated with SARS-CoV-2 Infection and COVID-19 Vaccination
Purvita Chowdhury, Shinjini Bhattacharya, Bhaskarjyoti Gogoi, Ravindra P. Veeranna, Sachin Kumar · 2022 · Vaccines
Emulating target trials of postexposure vaccines using observational data
Christopher Boyer, Marc Lipsitch · 2024 · American Journal of Epidemiology
COVID-19 vaccination is associated with reduced non-COVID in-hospital mortality
Jochanan Benbassat, Paul Froom, Zvi Shimoni · 2022 · Preventive Medicine
Waning Humoral Immune Response Following the Third and Fourth SARS‐COV‐2 Vaccine: A Cohort Study in Healthcare Workers
Ahmet Furkan Süner, Gül Ergör, Derya Çağlayan, Neslişah Türe, Irmak Güzel, Çağlar Irmak, Elif IŞIK, Özgür Appak, Muammer Çelik, Gamze Öztürk et al. · 2024 · Influenza and Other Respiratory Viruses
Immunogenicity and reactogenicity of repeated intradermal mRNA COVID-19 vaccines administered as a second booster dose in a Thai geriatric population
Prasert Assantachai, Suvimol Niyomnaitham, Zheng Quan Toh, Monthira Thammasalee, Napaporn Pengsorn, Wiyachatr Monklang, Paul Vincent Licciardi, Kulkanya Chokephaibulkit · 2024 · Frontiers in Immunology
Exploring risk factors for Raynaud's phenomenon post COVID-19 vaccination
Tzu‐Chuan Ho, Shih‐Chang Chuang, Kuo-Chen Hung, Chin-Chuan Chang, Kuo‐Pin Chuang, Cheng-Hui Yuan, Ming‐Hui Yang, Yu‐Chang Tyan · 2024 · Vaccine
Predictive factors of delayed viral clearance of asymptomatic Omicron-related COVID-19 screened positive in patients with cancer receiving active anticancer treatment
Victor Ho-Fun Lee, Sik-Kwan Chan, Yiu-Ho Tam, Tin‐Ching Chau, Jasper Fuk‐Woo Chan, Sum‐Yin Chan, Chun-Yat Ip, Cheuk‐Wai Choi, Sherry C.Y. Ng, Kwok-Keung Yuen · 2023 · International Journal of Infectious Diseases
Deficient Immune Response following SARS-CoV-2 Vaccination in Patients with Hepatobiliary Carcinoma: A Forgotten, Vulnerable Group of Patients
Malte B. Monin, Leona I. Baier, Jens Gabriel Gorny, Moritz Berger, Taotao Zhou, Robert Mahn, Farsaneh Sadeghlar, Christian Möhring, Christoph Boesecke, Kathrin van Bremen et al. · 2023 · Liver Cancer
Response Rate of the Third and Fourth Doses of the BNT162b2 Vaccine Administered to Cancer Patients Undergoing Active Anti-Neoplastic Treatments
Abed Agbarya, Ina Sarel, Tomer Ziv‐Baran, Orna Schwartz, Mohammad Sheikh‐Ahmad, Leonard Saiegh, Forat Swaid, Yelena Shechtman, Ella Kozlener, Rasha Khoury et al. · 2023 · Diseases
Yeast-Based Screening of Anti-Viral Molecules
Vartika Srivastava, Ravinder Kumar, Aijaz Ahmad · 2024 · Microorganisms
Effect of a biomimetic pathogen adsorbing device on inflammatory biomarkers in COVID‐19 patients
Jan Schmieszek, Thomas Fuehner, Isabelle Renger, Tobias Welte, Jan Menne, Jan Fuge, Maria P. van't Klooster, Andrea Paul, Alina Siegert, Dan‐Nicolae Borchina et al. · 2024 · Therapeutic Apheresis and Dialysis
Prevalence and associated factors of dysphonia in non-hospitalized Thai COVID-19 patients: a descriptive study with Thai-VHI10 Assessment
Thitaree Suwannutsiri, Peerada Arreenich, Premsuda Sombuntham · 2024 · Asian Biomedicine
Immunologic assessment of the impact of SARS-CoV-2 vaccine booster doses on humoral immunity: a cross-sectional study in morocco
Karima Abounouh, Tajudeen Raji, Hind Majidi, Soad Redwane, Oumaima Laazaazia, Safaa Aqillouch, Ahmed E Ogwell Ouma, Mohammed Abdulaziz, Merawi Aragaw, Mosoka Papa Fallah et al. · 2024 · BMC Infectious Diseases